Biofrontera (BFRI) Non-Current Assets (2020 - 2026)
Biofrontera (BFRI) posted quarterly Non-Current Assets of $10.5 million for Q4 2025, up 648.11% year-over-year from $1.4 million in Q4 2024, and up 946.01% quarter-over-quarter from $1.0 million in Q3 2025.
Biofrontera (BFRI) Non-Current Assets (2020 - 2026) Analysis & Trends
Biofrontera's Non-Current Assets history runs 6 years deep, the most recent figure standing at $10.5 million for Q4 2025.
- In Q4 2025, Non-Current Assets rose 648.11% year-over-year to $10.5 million; the TTM figure through Dec 2025 stood at $14.1 million (up 22.22% YoY), while the FY2025 annual figure was $10.5 million, up 648.11% from the prior year.
- Non-Current Assets for Q4 2025 stood at $10.5 million, up from $1.0 million in the prior quarter.
- The five-year high for Non-Current Assets was $10.5 million in Q4 2025, with the low at -$46.4 million in Q4 2021.
- The 5-year median for Non-Current Assets is $4.5 million (2023), against an average of $1.5 million.
- The sharpest annual moves came in 2021 and 2025: Non-Current Assets sank 1117.38% in 2021, then surged 648.11% in 2025.
- Biofrontera's Non-Current Assets stood at -$46.4 million in 2021, then jumped by 116.68% to $7.7 million in 2022, then plunged by 37.28% to $4.9 million in 2023, then sank by 71.16% to $1.4 million in 2024, then soared by 648.11% to $10.5 million in 2025.
- Business Quant data shows BFRI's Non-Current Assets at $10.5 million in Q4 2025, $1.0 million in Q3 2025, and $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 11.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.63 Mn |
| Dec 31, 2025 | 10.48 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 4.42 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 4.49 Mn |
| Mar 31, 2023 | 4.74 Mn |
| Dec 31, 2022 | 7.74 Mn |
| Sep 30, 2022 | 6.57 Mn |
| Jun 30, 2022 | 6.65 Mn |
| Mar 31, 2022 | 6.67 Mn |
| Dec 31, 2021 | -46.41 Mn |
| Sep 30, 2021 | 5.22 Mn |
| Dec 31, 2020 | 4.56 Mn |